State Street Corp Dyne Therapeutics, Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 3,355,678 shares of DYN stock, worth $39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,355,678

Previous 3,609,651 7.04%

Holding current value

$39 Million

Previous $37.8 Million 15.39%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.81 - $14.78 $1.73 Million - $3.75 Million	-253,973 Reduced 7.04%	3,355,678 $31.9 Million
Q1 2025 May 15, 2025	SELL	$10.46 - $25.46 $1.13 Million - $2.74 Million	-107,732 Reduced 2.9%	3,609,651 $37.8 Million
Q4 2024 Feb 14, 2025	BUY	$23.56 - $35.55 $1.78 Million - $2.68 Million	75,524 Added 2.07%	3,717,383 $87.6 Million
Q3 2024 Nov 14, 2024	BUY	$31.94 - $47.04 $14.1 Million - $20.7 Million	440,890 Added 13.77%	3,641,859 $131 Million
Q2 2024 Aug 14, 2024	SELL	$23.65 - $35.63 $23.5 Million - $35.4 Million	-992,584 Reduced 23.67%	3,200,969 $113 Million
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $24.2 Million - $54.2 Million	1,856,412 Added 79.43%	4,193,553 $119 Million
Q4 2023 Feb 14, 2024	BUY	$6.62 - $13.64 $2.64 Million - $5.44 Million	398,499 Added 20.56%	2,337,141 $31.1 Million
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $1.37 Million - $1.94 Million	158,902 Added 8.93%	1,938,642 $17.4 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $10.1 Million - $16.8 Million	1,178,928 Added 196.22%	1,779,740 $20 Million
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $268,398 - $370,035	24,669 Added 4.28%	600,812 $6.92 Million
Q4 2022 Feb 14, 2023	SELL	$9.37 - $13.8 $25,645 - $37,770	-2,737 Reduced 0.47%	576,143 $6.68 Million
Q3 2022 Nov 15, 2022	BUY	$7.2 - $15.17 $138,182 - $291,142	19,192 Added 3.43%	578,880 $7.35 Million
Q2 2022 Aug 15, 2022	BUY	$4.36 - $10.5 $256,006 - $616,528	58,717 Added 11.72%	559,688 $3.85 Million
Q1 2022 May 16, 2022	BUY	$6.52 - $12.27 $56,189 - $105,742	8,618 Added 1.75%	500,971 $4.83 Million
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $90,280 - $122,019	7,593 Added 1.57%	492,353 $5.85 Million
Q3 2021 Nov 15, 2021	BUY	$15.6 - $21.46 $403,478 - $555,041	25,864 Added 5.64%	484,760 $7.87 Million
Q2 2021 Aug 16, 2021	BUY	$15.94 - $22.33 $3.69 Million - $5.17 Million	231,492 Added 101.8%	458,896 $9.66 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $75,600 - $158,220	5,400 Added 2.43%	227,404 $3.53 Million
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $3.73 Million - $5.31 Million	222,004 New	222,004 $4.66 Million

Others Institutions Holding DYN

# of Institutions

220

Shares Held

121M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $602M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Dyne Therapeutics, Inc. Transaction History